Those at risk for severe COVID-19 often least likely to get monoclonal antibodies
People over age 65 at the highest risk for severe COVID-19 have often been the least likely to receive monoclonal antibodies (mAbs)
People over age 65 at the highest risk for severe COVID-19 have often been the least likely to receive monoclonal antibodies (mAbs)
For the past two months your mood has been low, you’ve lost your appetite, and you can’t sleep well. Your family is
A recent letter published in the journal Science aims to jump-start conversations on the importance of inclusive language in the sciences as
Some physicians are far more likely to deliver appropriate care than others in the same geographic area or health care system, according
As weary Americans hold out hope that the decline of Omicron signals an end to the pandemic’s emergency phase, physicians who treat
As more governors end mask mandates, and as Omicron fades and a range of new anti-COVID tools emerge, risk-reduction experts say that
Two treatments that have been shown to be ineffective against COVID-19 — hydroxychloroquine and ivermectin — were more heavily prescribed in the
In the late 1990s, Paul Farmer was usually the last doctor to leave the intensive care unit at Brigham and Women’s Hospital.
Even for those never infected with SARS-CoV-2, new research shows that lifestyle disruptions during the COVID-19 pandemic may have triggered inflammation in
Over the last several decades, cataract surgery has become exceptionally safe and rather routine in this country. Annually, an estimated 2 million